Skip to main content
SpringerLink
Log in

Community-acquired pneumonia and the role of levofloxacin in its management

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Perry CM, Goa KL. Community-acquired pneumonia and its management. The role of levofloxacin. Dis Manage Health Outcomes 2001; 9(1): 43–64

    Article  Google Scholar 

  2. Lieberman D, Lieberman D. Community-acquired pneumonia in the elderly. Drugs Aging 2000 Aug; 17(2): 93–105

    Article  PubMed  CAS  Google Scholar 

  3. Marrie TJ, Lau CY, Wheeler SL, et al. A critical pathway for the treatment of community-acquired pneumonia. Drugs 1999; 58 Suppl. 2: 273–75

    Article  Google Scholar 

  4. Marrie TJ. Incidence and clinical significance of the most common pathogens in community-acquired pneumonia. Infect Dis Clin Pract 1997 Nov; 6 Suppl. 2: S32–42

    Article  Google Scholar 

  5. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community acquired pneumonia in adults. Clin Infect Dis 2000; 31(2): 347–82

    Article  PubMed  CAS  Google Scholar 

  6. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000; 31(2): 383–421

    Article  PubMed  CAS  Google Scholar 

  7. Marston BJ, Plouffe JF, File Jr TM, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997; 157: 1709–18

    Article  PubMed  CAS  Google Scholar 

  8. Finch RG, Woodhead MA. Practical considerations and guidelines for the management of community-acquired pneumonia. Drugs 1998 Jan; 55(1): 31–45

    Article  PubMed  CAS  Google Scholar 

  9. British National Formulary. No 41. London: The Pharmaceutical Press, 2001, Mar: 256-87

  10. Antibiotic Guide, Johns Hopkins Division of Infectious Diseases [online]. Available from URL: http://hopkins-abxguide.org/main.cfm [Accessed 2001 Sep 24]

  11. Martin S, Jung R, Garvin CG. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections. Drug Saf 2001; 24(3): 199–222

    Article  PubMed  CAS  Google Scholar 

  12. Stahlmann R, Lode H. Toxicity of quinolones. Drugs 1999; 58 Suppl. 2: 37–42

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Community-acquired pneumonia and the role of levofloxacin in its management. Drugs Ther. Perspect 17, 1–5 (2001). https://doi.org/10.2165/00042310-200117240-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117240-00001

Keywords

Search

Navigation